Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare progression-free survival (PFS) between tivozanib in combination with mFOLFOX6 with bevacizumab in combination with mFOLFOX6 based on investigator radiological tumor assessment.
Critère d'inclusion
- Metastatic colorectal cancer (CRC)